medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2012, Number 1

<< Back Next >>

Acta Pediatr Mex 2012; 33 (1)

Varicella associated with group a beta hemolytic streptococcus infection. Importance of an early diagnosis

Río-Almendárez CN, Rivera-Silva G, López-Lizárraga ME, Moreno MG, Bolaños-Jiménez R, Arizmendi-Vargas J

Language: Spanish
References: 29
Page: 32-37
PDF size: 324.85 Kb.


ABSTRACT

Varicella is an acute viral exanthematic disease, common in childhood, with a high rate of complications, which may be fatal. These complications occur mainly in children with any kind of immunosuppression; bacterial infections are the most common. Since 1980, severe infections by Group A beta hemolytic streptococcus (GABHS) have resurged, affecting half of patients under 5 years with varicella. In order to remark that the best way to improve the prognosis of severe invasive infections caused by GAbHS is having knowledge of them and their early diagnosis and treatment, a review of these has been done.


REFERENCES

  1. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992;11:441-5.

  2. Delfin YL, Huerta GC, Miranda MG, Pacheco D, Solórzano F. Frecuencia y características clínicas de las infecciones de la piel y tejidos blandos en niños con varicela. Enf Inf Microbiol 2009;29:94-8.

  3. Maresova V, Maly M, Kyncl J, Bronska E, Benes C. Varicella and its complications: a five-year retrospective analysis of hospitalized patients. Antibiotiques 2006;8:131.

  4. Baldo V, Baldovin T, Russo F, Busana MC, Piovesan C, Bordignon G, et al. Varicella: epidemiological aspects and vaccination coverage in the Veneto region. BMC Infect Dis 2009;8:150.

  5. Tremolada S, Delbue S, Ferrante P. Viral infections of the fetus and newborn infant. Pediatr Med Chir 2008;30:177-91.

  6. Heininger U, Seward JF. Varicella. Lancet 2006;368:1365-76.

  7. Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one – and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine 2010;28:3385-97.

  8. Zimmerman RK, Tabbarah M, Bardenheier B, et al. The 2002 United States varicella vaccine shortage and physician recommendations for vaccination. Preventive Medicine 2005;41:575-82.

  9. Vugia DJ, Peterson CL, Meyers HB, et al. Invasive group A streptoccal infections in children with varicella in Southern California. Pediatr Infect Dis J 1996;15:146-50.

  10. Schwartz B, Breiman R, Hardegree MC, Jacobs R, Orenstein W, Rabinovich NR. Comité de enfermedades infecciosas. Academia Americana de Pediatría. Infecciones invasivas graves por estreptococo del grupo A: una revisión del tema. Pediatrics (ed esp) 1998;45:80-4.

  11. Losurdo G, Bertoluzzo L, Canale F, Timitilli A, Bondi E, Castagnola E, et al. Varicella and its complications as cause of hospitalization. Infez Med 2005;13:229-34.

  12. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005;41:839-47.

  13. Ferreira Santos C, Gomes A, Garrido A, Albuquerque A, Melo E, Barros I, et al. Varicella zoster pneumonia. Rev Port Pneumol 2010;16:493-505.

  14. Briko NI, Riapis LA, Dmitrieva NF. Mechanism of development of epidemic process of group A streptococcal infection in children collectives. Zh Mikrobiol Epidemiol Immunobiol 2010;2:17-20.

  15. Ulloa MT, Giglio MS, Porte L. Detección de los genes de las exotoxinas pirogénicas SpeA, SpeB y SpeC en cepas chilenas de Streptococcus pyogenes y su asociación con la clínica. Rev Med Chile 2000;128:27-34.

  16. Kohler W. Epidemiology and pathogenesis of streptococcal infection. Immun Infekt 1992;20:92-8.

  17. Kimoto H, Fujii Y, Yokota Y, Taketo A. Molecular characterization of NADase-streptolysin O operon of hemolytic streptococci. Biochim Biophys Acta 2005;1681:134-49.

  18. Shirley R, Mackey S, Meagher P. Necrotizing fasciitis: A sequelae of varicella zoster infection. J Plast Reconstr Anesthet Surg 2010;63:233–9.

  19. Floret D. Clinical aspects of streptococcal and staphylococcal toxic diseases. Arch Pediatr 2001;8(Suppl 4):762s-8s.

  20. Stevens DL, Eron LL. Cellulitis and soft-tissue infections. Ann Intern Med 2009;150:ITC11.

  21. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373-406.

  22. Vinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect Dis 2005;5:501-13.

  23. Stevens DL. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis and new concepts in treatment. Emerg Infect Dis 1995;1:69-78.

  24. Bueno PM, Marino J, Bueno JC, Martínez C, Bueno E. Fascitis necrotizante. Rev Cubana Ortop Traumatol 1999;13:47-53.

  25. Giuliano A, Lewis F, Hadley K, Williams F. Bacteriology of necrotizing fasciitis. Am J Surg 1997;134:52-7.

  26. Irribaren O. Necrotizing soft tissue infection. Rev Med Chile 1996;124:1099-105.

  27. Bliss DP, Healey PJ, Waldhausen JH. Necrotizing fasciitis after Plastibell circumcision. J Pediatr 1997;131:459-62.

  28. Noya E, Tezano E, Días C, Balboa de Paz F, Casado de Frías E. Fascitis necrotizante estreptocócica. An Esp Pediatr 1991;35:362-4.

  29. Holm SE. Editorial. Invasive group A streptococcal infections. N Engl J Med 1996;335-8.




2020     |     www.medigraphic.com